Eye Movement Behaviour and Pupil Size in Natural Outdoor and Indoor Scenes

NCT ID: NCT05971238

Last Updated: 2023-08-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-01

Study Completion Date

2024-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the researchers will be using eye tracking and detailed lighting measurements to understand how different types of indoor and outdoor lighting affect the eye movements and pupil sizes of our participants. Participants will be paired up and undergo six eye tracking sessions, split across two appointments. Each appointment will involve viewing either indoor or outdoor scenes, and before each session, participants will spend time adapting to the lighting conditions. Overall, each participant will spend 24 minutes being tracked, and the entire study will take about 2-3 hours to complete. The investigators expect differences in eye movements and pupil size between indoor and outdoor scenes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Light Sensitivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

All participants will be exposed to the same environmental conditions (same indoor and outdoor scenes for the same duration) and the captured eye-movement data of every participant will be of the same type. Participants will be exposed to different orders of scene sequences.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Eye-tracking, pupillometry and scene rating indoors & outdoors

Group Type EXPERIMENTAL

Indoor vs. outdoor scenes

Intervention Type OTHER

Light conditions in indoor (artificial light) and outdoor (daylight) settings

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Indoor vs. outdoor scenes

Light conditions in indoor (artificial light) and outdoor (daylight) settings

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* No previous eye-surgeries or ocular impairments like anisometropia, amblyopia, strabism, cataract, watery eyes or hanging eye lids
* Normal or corrected-to-normal visual acuity (+3dpt. to -5dpt.)
* Normal colour vision
* Normal binocular vision

Exclusion Criteria

* Any use of medications or drugs that influence photosensitivity or the ability to concentrate
* Excessive alcohol and/or drug use
* Presence of psychiatric disorders
* Poor sleep quality
* Diagnosed with epilepsy
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Max-Planck Institute for Biological Cybernetics

OTHER

Sponsor Role collaborator

Technical University of Munich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Manuel Spitschan

Assistant Professor of Chronobiology & Health

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Manuel Spitschan, PhD

Role: PRINCIPAL_INVESTIGATOR

Technical University of Munich & Max Planck Institute for Biological Cybernetics

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Max Planck Institute for Biological Cybernetics

Tübingen, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alexander Hahn

Role: CONTACT

+49(0)70716011670

Manuel Spitschan, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alexander Hahn

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-231-S-KH

Identifier Type: OTHER

Identifier Source: secondary_id

MPI-TSCN-2023-NATURALEYE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Eye Movements in Visual Search
NCT05472961 WITHDRAWN NA
Mechanisms of Perceptual Learning
NCT06822101 ENROLLING_BY_INVITATION NA